New reports on the South African strain of the coronavirus:
- Studies on the efficacy of current Pfizer vaccines should be available within 2 weeks
- It takes about 100 days to adapt the vaccine to a new variant (Pfizer)
- European Union points out that the new virus variant is a cause for concern
- European Commission is considering banning travel to and from countries where the new variant has been detected (some of these countries already canceled several flights to EU)
- The German Minister of Health points to the seriousness of the current situation
- Vaccine manufacturers' share prices rose sharply, stock indexes attempt to rebound, gold erased half of today's gains
As you can see, Friday's session, which was supposed to be boring due to low volatility, turned out to be completely different. We certainly won't get all the answers today, however it seems that the initial market reaction may have been exaggerated.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appThis content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
